Parkinson’s patients use telehealth access for speech improvement during pandemic

WEST LAFAYETTE, Ind. – SpeechVive Inc. announced Thursday (Nov. 19) it is making its remote calibration software and training available free during the COVID-19 global health crisis. The software and training are available to all speech-language pathologists and their patients,…

Aarhus University links brain research and artificial intelligence in new centre

A new cross-disciplinary centre will develop brain-machine interface technologies. One of the goals is to develop next-gen technology to monitor, diagnose, and treat brain diseases while at the same time developing brand new brain-inspired AI hardware.

First Non-human primate study showing promise of gene therapy for stroke repair

Stroke is a leading cause of death and severe long-term disability with limited treatment available. A research team led by Prof. Gong Chen at Jinan University, Guangzhou, China recently reported the first non-human primate study demonstrating successful in vivo neural…

Innovative machine-learning approach for future diagnostic advances in Parkinson’s disease

Parkinson’s disease (PD) is the second most common neurodegenerative disease, with patient numbers being expected to double worldwide in the next 20 years. The detailed molecular and cellular mechanisms underlying its pathogenesis remains unclear, although recent evidence has pointed towards…

Experts detail evidence base for cognitive rehabilitation for neurological conditions

In ‘Cognitive Rehabilitation and Neuroimaging’, Kessler Foundation scientists focus on the advances being achieved through the application of neuroimaging techniques to cognitive rehabilitation research in disabling neurological conditions

Shimmer Research receives CE certification for its Verisense™ Inertial Measurement Unit (IMU) sensor for clinical trials

Shimmer’s wearable sensor is now recognized as a medical device in Europe, capable of providing continuous, medical-grade measurements of a person’s activity

Key players join forces to tackle unmet needs in Parkinson’s disease

“The protein alpha-synuclein is thought to play a central role in neurodegenerative diseases, and is one of the most investigated targets for developing diagnostics and therapies for Parkinson’s disease,” explains Hilal Lashuel, director of the Lashuel lab at EPFL’s School…

Research News Tip Sheet: Story Ideas From Johns Hopkins Medicine

During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every other Tuesday.

Cancer anti-sickness drug offers hope for hallucinations in Parkinson’s

Monday 26 October 2020 – A world-first double-blind clinical trial, will investigate if a powerful drug used to treat nausea in chemotherapy patients, could alleviate hallucinations in people with Parkinson’s. Parkinson’s UK, the largest charitable funder of Parkinson’s research in…

Diagnosing Parkinson’s disease with skin samples could lead to earlier detection

New research shows a simple skin test can accurately identify Parkinson’s disease, which could lead to earlier detection of the disease and better outcomes for patients. Currently, Parkinson’s disease is diagnosed by clinical signs and symptoms but only definitively diagnosed at autopsy. The researchers conducted a blinded study of 50 skin samples using an assay originally designed to detect mad cow disease.

Lineage tracing of direct astrocyte-to-neuron conversion for brain repair

Regeneration of functional new neurons to repair injured human brain is a long-term unsolved problem up till today. The lack of neuroregeneration is one of the major reasons why so many brain disorders such as stroke and Alzheimer’s disease do…

Scientists find neurochemicals have unexpectedly profound roles in the human brain

Dopamine and serotonin are at work at sub-second speeds to shape how people perceive the world and take action based on their perception. The discovery shows researchers can simultaneously measure the activity of both dopamine and serotonin in disorders ranging from depression to Parkinson’s disease.

Improved Mobility in Frail and Elderly Adults Linked to Common Gene Variant

Contact: Allison Hydzik Office: 412-647-9975 Mobile: 412-559-2431 E-mail: [email protected] Contact: Erin Hare Office: 412-864-7194 Mobile: 412-738-1097 E-mail: [email protected] FOR IMMEDIATE RELEASE Better Mobility in Frail and Older Adults Linked to Common Gene Variant PITTSBURGH, Oct. 12, 2020 – Variations in…

Presented a program capable of detecting neurodegeneration biomarkers through magnetic

Magnetic resonance imaging is the most sensitive and reliable technique for diagnosing and monitoring neurodegenerative diseases. Through the images obtained, we can make a complete anatomical analysis of the brain and detect atrophy in specific regions. However, the inspection of…

$5.5 million NIH grant supports new tests to diagnose dementias earlier and easier

Researchers at Case Western Reserve University seek to optimize emerging methods of diagnosing two common neurodegenerative diseases — dementia with Lewy bodies and Parkinson’s disease dementia — which affect 1.4 million in the United States

Strength Training Improves Muscle Strength, Neuromuscular Function in Parkinson’s Disease

Article title: Maximal strength training in patients with Parkinson’s disease: Impact on efferent neural drive, force generating capacity, and functional performance Authors: Jan Helgerud, Simon Nørskov Thomsen, Jan Hoff, Arild Strandbråten, Gunnar Leivseth, Runar Jakobsen Unhjem, Eivind Wang From the…